0001179110-19-003446.txt : 20190306 0001179110-19-003446.hdr.sgml : 20190306 20190306170414 ACCESSION NUMBER: 0001179110-19-003446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190304 FILED AS OF DATE: 20190306 DATE AS OF CHANGE: 20190306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dorsch Marion CENTRAL INDEX KEY: 0001690460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 19663287 MAIL ADDRESS: STREET 1: BLUEPRINT MEDICINES CORPORATION STREET 2: 38 SIDNEY STREET, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2019-03-04 0 0001597264 Blueprint Medicines Corp BPMC 0001690460 Dorsch Marion C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Scientific Officer Common Stock 2019-03-04 4 M 0 2300 37.11 A 2300 D Common Stock 2019-03-04 4 S 0 295 87.73 D 2005 D Common Stock 2019-03-04 4 S 0 498 85.64 D 1507 D Common Stock 2019-03-04 4 S 0 600 84.72 D 907 D Common Stock 2019-03-04 4 S 0 800 83.16 D 107 D Common Stock 2019-03-04 4 S 0 107 82.56 D 0 D Stock Option (Right to Buy) 37.11 2019-03-04 4 M 0 2300 0 D 2026-11-21 Common Stock 2300 75600 D Effected pursuant to a trading plan adopted on December 18, 2017 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.57 to $88.04 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.24 to $86.19 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.17 to $85.05 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.63 to $83.58 per share. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.53 to $82.56 per share. This option was granted on November 21, 2016. This option vested with respect to 25% of the shares underlying the option on November 21, 2017 and vests as to an additional 1/48th of the shares underlying the option each month thereafter. /s/ Christopher Frankenfield, Attorney-in-Fact 2019-03-06